Knott V

References (5)

Title : Combining CDP-choline and galantamine, an optimized alpha7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia - Choueiry_2019_Int.J.Psychophysiol_145_70
Author(s) : Choueiry J , Blais CM , Shah D , Smith D , Fisher D , Labelle A , Knott V
Ref : Int J Psychophysiol , 145 :70 , 2019
Abstract :
PubMedSearch : Choueiry_2019_Int.J.Psychophysiol_145_70
PubMedID: 30790597

Title : Nicotine and sensory memory in Alzheimer's disease: an event-related potential study - Engeland_2002_Brain.Cogn_49_232
Author(s) : Engeland C , Mahoney C , Mohr E , Ilivitsky V , Knott V
Ref : Brain Cogn , 49 :232 , 2002
Abstract :
PubMedSearch : Engeland_2002_Brain.Cogn_49_232
PubMedID: 15259398

Title : Effects of acute nicotine administration on cognitive event-related potentials in tacrine-treated and non-treated patients with Alzheimer's disease - Knott_2002_Neuropsychobiology_45_156
Author(s) : Knott V , Mohr E , Mahoney C , Engeland C , Ilivitsky V
Ref : Neuropsychobiology , 45 :156 , 2002
Abstract :
PubMedSearch : Knott_2002_Neuropsychobiology_45_156
PubMedID: 11979067

Title : Acute nicotine administration in Alzheimer's disease: an exploratory EEG study - Knott_2000_Neuropsychobiology_41_210
Author(s) : Knott V , Engeland C , Mohr E , Mahoney C , Ilivitsky V
Ref : Neuropsychobiology , 41 :210 , 2000
Abstract :
PubMedSearch : Knott_2000_Neuropsychobiology_41_210
PubMedID: 10828731

Title : Pharmaco-EEG test dose response predicts cholinesterase inhibitor treatment outcome in Alzheimer's disease - Knott_2000_Methods.Find.Exp.Clin.Pharmacol_22_115
Author(s) : Knott V , Mohr E , Mahoney C , Ilivitsky V
Ref : Methods Find Exp Clin Pharmacol , 22 :115 , 2000
Abstract :
PubMedSearch : Knott_2000_Methods.Find.Exp.Clin.Pharmacol_22_115
PubMedID: 10849895